iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionPutnam Fl Investment Management Co
Latest Disclosed Ownership2,099 shares
Latest Disclosed Value $ 354,448
Putnam Fl Investment Management Co reports 3.67% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 5, 2026 - Putnam Fl Investment Management Co filed a 13F-HR form disclosing ownership of 2,099 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $354,448 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,179 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -3.67% during the quarter. The current value of the position is $275,074 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,099 -80 -3.67 354 -3.54 0.0053
2026-02-09 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,179 0 0.00 368 16.88 0.0053
2025-10-10 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,179 105 5.06 315 19.85 0.0047
2025-08-12 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,074 -49 -2.31 262 -3.32 0.0045
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,123 397 23.00 272 18.86 0.0051
2025-02-05 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,726 9 0.52 228 -8.43 0.0042
2024-11-08 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,717 -9 -0.52 250 5.51 0.0045
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,726 224 14.91 237 14.56 0.0044
2024-05-03 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,502 0 0.00 206 0.98 0.0044
2024-01-30 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,502 1,502 204 0.0048
2023-04-27 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 0 -1,755 -100.00 0 -100.00
2023-01-31 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,755 -30 -1.68 230 10.05 0.0084
2022-11-07 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,785 -298 -14.31 209 -14.69 0.0081
2022-08-08 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,083 19 0.92 245 -8.92 0.0090
2022-04-28 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,064 -135 -6.14 269 -19.94 0.0086
2022-02-15 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,199 -92 -4.02 336 -9.19 0.0103
2021-10-26 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,291 -69 -2.92 370 -4.15 0.0126
2021-08-11 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,360 -29 -1.21 386 7.22 0.0133
2021-05-14 2021-03-31 13F iShares Nasdaq Biotechnology I COM 464287556 2,389 -360 -13.10 360 -13.46 0.0158
2021-02-02 2020-12-31 13F iShares Nasdaq Biotechnology I COM 464287556 2,749 -63 -2.24 416 9.19 0.0195
2020-11-03 2020-09-30 13F iShares Nasdaq Biotechnology I COM 464287556 2,812 -727 -20.54 381 -21.28 0.0209
2020-08-13 2020-06-30 13F iShares Nasdaq Biotechnology I COM 464287556 3,539 43 1.23 484 28.38 0.0288
2020-05-08 2020-03-31 13F iShares Nasdaq Biotechnology I COM 464287556 3,496 -219 -5.90 377 -15.85 0.0286
2020-01-30 2019-12-31 13F iShares Nasdaq Biotechnology I NASDAQ BIOTECH 464287556 3,715 -95 -2.49 448 18.21 0.0275
2019-11-05 2019-09-30 13F iShares Nasdaq Biotechnology I NASDAQ BIOTECH 464287556 3,810 2,127 126.38 379 105.98 0.0267
2019-07-25 2019-06-30 13F iShares Nasdaq Biotechnology I COM 464287556 1,683 -236 -12.30 184 -14.42 0.0148
2019-05-15 2019-03-31 13F iShares Nasdaq Biotechnology I COM 464287556 1,919 1,919 215 0.0181
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.